2023-03-30 06:04:30 ET
- Rockwell Medical press release ( NASDAQ: RMTI ): Q4 GAAP EPS of -$0.20 beats by $0.19 .
- Revenue of $19.3M (+26.1% Y/Y) beats by $2.99M .
- “For 2023, we plan to continue to focus on growing our hemodialysis concentrates business by enhancing the economics within our current customer agreements, adding new long-term supply agreements with new customers, continuing to reduce expenses, lowering our debt, and driving our business to profitability."
- The company expects net sales between $78M to $82M vs. consensus of $78.43M and gross profit in the range of $7M to $9M for FY2023.
For further details see:
Rockwell Medical GAAP EPS of -$0.20 beats by $0.19, revenue of $19.3M beats by $2.99M